Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 1/20 | 0.52 |
| ▸ | DDIT3 | P35638 | 1/20 | 0.51 |
| ▸ | MITF | O75030 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25005925 | 0.95 | EPHX2 (0.63) | EPHX2POLBKMT2AMAPTMEN1 | |
| SCHEMBL25005417 | 0.79 | JAK2 (0.67) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL25006066 | 0.78 | JAK2 (0.61) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL24291456 | 0.78 | LMNA (0.71) | KMT2AMAPTMEN1LMNARAB9A | |
| SCHEMBL6427938 | 0.77 | RAB9A (0.78) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL29462146 | 0.76 | POLB (0.54) | POLBMAPTLMNARAB9AALDH1A1 | |
| SCHEMBL25005574 | 0.76 | JAK2 (0.64) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL22822784 | 0.76 | JAK2 (0.58) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL22822605 | 0.75 | JAK2 (0.72) | POLBKMT2AMAPTMEN1LMNA | |
| SCHEMBL29462179 | 0.75 | JAK2 (0.72) | POLBKMT2AMAPTMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112107568-B | Diaryl amide compound and application thereof | 北京龙嘉博创医药科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-112107568-A | Diaryl amide compound and application thereof | 北京大学 | 2020-12-22 | — | — | CN | claimed |
| US-20230045031-A1 | Diarylamide Compound and Application Thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| EP-3984534-A1 | DIARYLAMIDE COMPOUND AND APPLICATION THEREOF | Peking University (CN) | 2022-04-20 | — | — | EP | disclosed |
| CN-112107568-B | Diaryl amide compound and application thereof | 北京龙嘉博创医药科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-112107568-A | Diaryl amide compound and application thereof | 北京大学 | 2020-12-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230045031-A1 | Diarylamide Compound and Application Thereof | SLC14A1, SLC28A1, SLC28A2 | EPHX2 3260/4885POLB 4479/4885KMT2A 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.